Aspira Women's Health Announces Preliminary First Quarter 2023 OvaSuite Volume Increase of 29% and Plans to Announce Full Earnings Results on May 11, 2023GlobeNewsWire • 04/27/23
Aspira Women's Health Reports Fourth Quarter and Full Year 2022 Financial ResultsGlobeNewsWire • 03/22/23
Has Aspira Women's Health (AWH) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 03/21/23
Aspira Women's Health to Announce Year End 2022 Financial Results and Host Conference Call on March 22, 2023GlobeNewsWire • 03/03/23
Aspira Women's Health Announces Preliminary Fourth Quarter 2022 Volume, Preliminary Results in Line with Cash Utilization Guidance, and Other HighlightsGlobeNewsWire • 01/09/23
Aspira Women's Health Announces Publication of Real-World Data Validating Use of OvaWatch for the Management of Adnexal MassesGlobeNewsWire • 01/06/23
Aspira Women's Health Announces Three Reimbursement Milestones that Improve Patient Access to its OvaSuite SM Testing PortfolioGlobeNewsWire • 12/27/22
Aspira Women's Health to Participate at the Upcoming MicroCap Rodeo Windy City Roundup 2022GlobeNewsWire • 10/06/22
Aspira Women's Health Announces Publication of its Second-Generation MultiVariate Index Assay, OVERA®, in the Detection of Cancer in Filipino WomenGlobeNewsWire • 09/12/22
Down 38.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Aspira (AWH)Zacks Investment Research • 08/24/22
Aspira Women's Health Hosting Women's Health Webinar on Ovarian Cancer Risk Assessments Utilizing Multivariant Index AssayGlobeNewsWire • 08/18/22
Aspira Women's Health, Inc. (AWH) CEO Nicole Sandford on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/10/22
Aspira Women's Health to Announce Second Quarter 2022 Financial Results and Host Conference Call on Wednesday, August 10GlobeNewsWire • 08/01/22